World Investment Advisors LLC Buys 20,308 Shares of CVS Health Co. (NYSE:CVS)

World Investment Advisors LLC lifted its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 280.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 27,543 shares of the pharmacy operator's stock after buying an additional 20,308 shares during the period. World Investment Advisors LLC's holdings in CVS Health were worth $1,732,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. State Street Corp lifted its stake in shares of CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after purchasing an additional 1,989,066 shares in the last quarter. Geode Capital Management LLC grew its holdings in CVS Health by 1.8% during the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock worth $1,651,997,000 after acquiring an additional 461,569 shares during the period. Pzena Investment Management LLC lifted its holdings in shares of CVS Health by 1.5% during the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock valued at $825,948,000 after purchasing an additional 198,920 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of CVS Health by 2.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock valued at $767,681,000 after acquiring an additional 304,386 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of CVS Health by 34.8% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after purchasing an additional 3,071,613 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Down 0.4 %

CVS traded down $0.21 during trading on Friday, reaching $49.37. The company had a trading volume of 17,647,663 shares, compared to its average volume of 11,382,666. The business's fifty day moving average price is $58.34 and its 200 day moving average price is $58.64. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 12 month low of $48.01 and a 12 month high of $83.25. The company has a market cap of $62.13 billion, a P/E ratio of 12.53, a PEG ratio of 0.89 and a beta of 0.54.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.21 earnings per share. Equities analysts anticipate that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 5.39%. CVS Health's dividend payout ratio is currently 67.51%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Royal Bank of Canada dropped their price objective on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. Evercore ISI boosted their price objective on CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research report on Tuesday, October 8th. TD Cowen increased their price objective on CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, November 25th. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $60.00 to $66.00 in a research note on Monday, November 18th. Finally, UBS Group raised their price target on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $70.50.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.